Representations for graphical user interfaces of operators, data types, and data values in a plurality of natural languages
    5.
    发明授权
    Representations for graphical user interfaces of operators, data types, and data values in a plurality of natural languages 有权
    多种自然语言中运算符,数据类型和数据值的图形用户界面的表示

    公开(公告)号:US08548798B2

    公开(公告)日:2013-10-01

    申请号:US12981687

    申请日:2010-12-30

    IPC分类号: G06F17/28

    CPC分类号: G06F8/34 G06F9/454

    摘要: A natural language-independent computer program is constructed. A data element is defined by a graphical representation in a user interface. A data element has a data type and a value. An operator is defined on multiple data elements by association of the graphical representations in the user interface. A natural language-independent graph data structure is defined by the association of data elements representing the logic of a computer program. The data types and operators have referenced descriptions in one or more natural languages, enabling a logical expression such as a computer program to be defined and understood in one or more natural languages.

    摘要翻译: 构建了与自然语言无关的计算机程序。 数据元素由用户界面中的图形表示来定义。 数据元素具有数据类型和值。 通过用户界面中的图形表示的关联在多个数据元素上定义运算符。 自然语言无关图形数据结构由表示计算机程序逻辑的数据元素的关联定义。 数据类型和操作符已经以一种或多种自然语言引用描述,使得能够以一种或多种自然语言来定义和理解诸如计算机程序之类的逻辑表达式。

    Methods for utilizing human perceptual systems for processing event log data
    7.
    发明授权
    Methods for utilizing human perceptual systems for processing event log data 失效
    利用人感知系统处理事件日志数据的方法

    公开(公告)号:US07995062B2

    公开(公告)日:2011-08-09

    申请号:US12041874

    申请日:2008-03-04

    申请人: Xiaoming Zhang

    发明人: Xiaoming Zhang

    IPC分类号: G06T11/20

    摘要: A method is provided for utilizing the human perceptual system by providing a spectrum of event log data for viewing. Event log data is received. Events of the event log data are mapped to an x-axis of a spectrum based on time, where the events of the event log data correspond to a time slot on the x-axis. Categories for the events are mapped to a y-axis of the spectrum, where the y-axis is a frequency axis, and where each of the categories respectively corresponds to a frequency of the multiple frequencies. Strength of events are mapped to a z-axis of the spectrum, where the z-axis is a magnitude axis, and where a magnitude value reflects the significance of the events happened at a particular time slot in a particular category. The magnitude of events (z-axis) of the event log data may be further mapped to a line thickness of the spectrum for the multiple frequencies. The spectrogram of the event log data is presented in a two-dimensional graphical format in time, frequency, and magnitude for observation by a user.

    摘要翻译: 提供了一种通过提供用于观看的事件日志数据的频谱来利用人类感知系统的方法。 收到事件日志数据。 基于时间将事件日志数据的事件映射到频谱的x轴,其中事件日志数据的事件对应于x轴上的时隙。 事件的类别被映射到频谱的y轴,其中y轴是频率轴,并且其中每个类别分别对应于多个频率的频率。 事件的强度被映射到频谱的z轴,其中z轴是幅度轴,并且其中幅度值反映在特定类别中的特定时隙发生的事件的重要性。 可以将事件对数数据的事件(z轴)的大小进一步映射到多个频率的频谱的线宽。 事件日志数据的频谱以时间,频率和大小的二维图形格式呈现,以供用户观察。

    Materials and Methods for Treating Coagulation Disorders
    8.
    发明申请
    Materials and Methods for Treating Coagulation Disorders 审中-公开
    治疗凝血障碍的材料和方法

    公开(公告)号:US20080221204A1

    公开(公告)日:2008-09-11

    申请号:US12125623

    申请日:2008-05-22

    IPC分类号: A61K31/352 A61P7/02

    摘要: This invention is drawn to compounds which are more easily metabolized by the metabolic drug detoxification systems. Particularly, warfarin analogs which have been designed to include esters within the structure of the compounds are taught. The invention teaches methods of reducing the toxicity of drugs comprising the introduction of ester groups into drugs during the synthesis of the drug. This invention is also drawn to methods of treating coagulation disorders comprising the administration of compounds which have been designed to be metabolized by serum or intracellular hydrolases and esterases. Pharmaceutical compositions of the ester containing warfarin, analogs are also taught.

    摘要翻译: 本发明涉及更容易被代谢药物解毒系统代谢的化合物。 特别地,教导了被设计成在化合物的结构内包含酯的华法林类似物。 本发明教导了在药物合成期间降低包括将酯基引入药物的药物的毒性的方法。 本发明还涉及治疗凝血障碍的方法,其包括施用被设计为由血清或细胞内水解酶和酯酶代谢的化合物。 还教导了含有华法林酯类药物组合物。